Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Est. Listeners
Insufficient chart data. Estimates will improve as the show charts.
- Per-Episode Audience
Est. listeners per new episode within ~30 days
N/A🎙 ~2x weekly·100 episodes·Last published 2mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
N/A - Active Followers
Loyal subscribers who consistently listen
N/A
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 14 epsHosts
Recent guests
Recent episodes
“A Lot More Asymptomatic Cancer Out There”: Major MCED Trial Hints at Complicated Future
Jun 23, 2026
15m 03s
“The Ever-Shifting and Chaotic” State of CLL Care: What New Data Mean for Practice
Jun 23, 2026
13m 59s
How “Drastically Better” Treatments for Some Colorectal Cancers Are Changing Care
Jun 17, 2026
16m 13s
“Not a Straightforward Decision”: What to Do While Waiting on a Practice Change in Breast Cancer Care
Apr 29, 2026
10m 53s
New Targeted Therapies Make Breast Cancer Treatment Decisions “a Bit of a Moving Target”
Apr 21, 2026
9m 28s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/23/26 | multicancer early detectioncancer biology+3 | Eric Klein, MDRobert Figlin, MD | NHS-GalleriOncology News Central | — | asymptomatic cancerNHS-Galleri+3 | — | 15m 03s | ||
| 6/23/26 | CLL carenew data+4 | Matthew Lunning, DO | American Society of Clinical Oncology | — | CLLchronic lymphocytic leukemia+4 | — | 13m 59s | ||
| 6/17/26 | colorectal cancermicrosatellite instability+3 | Nicholas James Hornstein, MD, PhD | American Society of Clinical OncologyOncology News Central | — | colorectal cancermicrosatellite instability+3 | — | 16m 13s | ||
| 4/29/26 | breast cancertreatment decisions+3 | Marla Lipsyc-Sharf, MD | Oncology News Central | — | breast cancerESR1 mutation+3 | — | 10m 53s | ||
| 4/21/26 | breast cancertargeted therapies+4 | Hope S. Rugo, MDHope S. Rugo | City of Hope Comprehensive Cancer CenterCedars-Sinai Cancer | — | breast cancertargeted therapies+6 | — | 9m 28s | ||
| 4/17/26 | ESR1-mutated breast cancertreatment decisions+3 | Hope S. Rugo, MDRobert A. Figlin, MD | City of Hope Comprehensive Cancer CenterCedars-Sinai Cancer | Duarte, CaliforniaLos Angeles | ESR1 mutationbreast cancer+3 | — | 12m 14s | ||
| 4/2/26 | breast cancerESR1 mutation+4 | Wassim Mchayleh, MD, MBA | University of Michigan Rogel Cancer CenterAdventHealth Cancer Institute+1 | — | breast cancer careESR1 mutation+3 | — | 14m 17s | ||
| 12/18/25 | shared decision makingtoxicity management+4 | Jorge Nieva, MD | Oncology News CentralEGFR- Mutated Advanced NSCLC | — | EGFRNSCLC+6 | — | 11m 48s | ||
| 12/18/25 | CNS diseaseEGFR-mutated NSCLC+4 | Sid Devarakonda, MDAakash Desai, MD, MPH | subcutaneous amivantamab (Rybrevant Faspro)Swedish Cancer Institute+2 | — | CNS diseaseEGFR mutation+5 | — | 14m 32s | ||
| 12/16/25 | EGFRm NSCLCtreatment intensification+3 | Jorge Nieva, MD | Oncology News Central | — | EGFRm NSCLCtreatment regimens+3 | — | 12m 56s | ||
| 12/15/25 | palliative careoncology+4 | Sunita Puri, MDSunita Puri | University of California Irvine School of MedicineCedars-Sinai Cancer Center+1 | — | oncologypalliative care+5 | — | 15m 59s | ||
| 11/21/25 | mRNA vaccinescancer immunotherapy+3 | Steven H. Lin, MD, PhD | University of Texas MD Anderson Cancer CenterCedars-Sinai Cancer Center | — | mRNA vaccinescancer+5 | — | 12m 38s | ||
| 10/30/25 | bladder canceroncology+3 | Amanda Nizam, MDRobert A. Figlin, MD | Cleveland Clinic Taussig Cancer InstituteCedars-Sinai Cancer+2 | — | bladder cancerKEYNOTE-905+5 | — | 11m 39s | ||
| 10/20/25 | acute myeloid leukemiatargeted therapies+3 | Amir Fathi, MDRobert A. Figlin, MD | Harvard Medical SchoolMassachusetts General Hospital+1 | BostonLos Angeles | acute myeloid leukemiaAML+3 | — | 11m 09s |
Showing 14 of 14
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.